Trimethylamine-d9 N-oxide
CAY-31449-10 10 mg
Data Sheet: 
SDS:
SDS:
CAS
1161070-49-0
Formulation
A solid
Purity
≥99% deuterated forms (d1-d9)
MW
84,2
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
Trimethylamine-d9 N-oxide is intended for use as an internal standard for the quantification of trimethylamine N-oxide (Item No. 17354) by GC- or LC-MS. Trimethylamine N-oxide (TMAO) is a metabolite of choline, phosphatidylcholine, and L-carnitine (Item No. 21489).{54307} It is formed by gut microbiota-mediated metabolism of choline, phosphatidylcholine, and L-carnitine to TMA followed by oxidation of TMA by flavin-containing monooxygenase 3 (FMO3) in the liver.{54307,54308,32692} Dietary administration of TMAO (0.12% w/w) increases renal tubulointerstitial fibrosis, collagen deposition, and Smad3 phosphorylation in mice and increases aortic lesion area in atherosclerosis-prone ApoE-/- mice.{54307,54309} Plasma levels of TMAO are elevated in patients with chronic kidney disease and decreased in patients with active, compared with inactive, ulcerative colitis.{54307,54308} Elevated plasma levels of TMAO are associated with increased risk of cardiovascular disease.{54309}
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
